BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mishra R, Haldar S, Suchanti S, Bhowmick NA. Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocr Relat Cancer 2019;26:R673-88. [PMID: 31627186 DOI: 10.1530/ERC-19-0347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Mollah F, Varamini P. Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts. Biomedicines 2021;9:1921. [PMID: 34944738 DOI: 10.3390/biomedicines9121921] [Reference Citation Analysis]
2 Louault K, Li RR, DeClerck YA. Cancer-Associated Fibroblasts: Understanding Their Heterogeneity. Cancers (Basel) 2020;12:E3108. [PMID: 33114328 DOI: 10.3390/cancers12113108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
3 Karin M, Shalapour S. Regulation of antitumor immunity by inflammation-induced epigenetic alterations. Cell Mol Immunol 2021. [PMID: 34465885 DOI: 10.1038/s41423-021-00756-y] [Reference Citation Analysis]
4 Ping Q, Yan R, Cheng X, Wang W, Zhong Y, Hou Z, Shi Y, Wang C, Li R. Cancer-associated fibroblasts: overview, progress, challenges, and directions. Cancer Gene Ther 2021. [PMID: 33712707 DOI: 10.1038/s41417-021-00318-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Shen M, Kang Y. Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities. Genes Dev 2020;34:1577-98. [PMID: 33262145 DOI: 10.1101/gad.343251.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Delinassios JG, Hoffman RM. The cancer-inhibitory effects of proliferating tumor-residing fibroblasts. Biochim Biophys Acta Rev Cancer 2021;:188673. [PMID: 34953931 DOI: 10.1016/j.bbcan.2021.188673] [Reference Citation Analysis]
7 Patra S, Elahi N, Armorer A, Arunachalam S, Omala J, Hamid I, Ashton AW, Joyce D, Jiao X, Pestell RG. Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors. Front Oncol 2021;11:700629. [PMID: 34631530 DOI: 10.3389/fonc.2021.700629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Su SF, Ho H, Li JH, Wu MF, Wang HC, Yeh HY, Kuo SW, Chen HW, Ho CC, Li KC. DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a smoking-associated malignancy index. J Clin Invest 2021;131:139552. [PMID: 34228648 DOI: 10.1172/JCI139552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Imlimthan S, Moon ES, Rathke H, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E. New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals (Basel) 2021;14:1023. [PMID: 34681246 DOI: 10.3390/ph14101023] [Reference Citation Analysis]
10 Zhu Z, Achreja A, Meurs N, Animasahun O, Owen S, Mittal A, Parikh P, Lo TW, Franco-Barraza J, Shi J, Gunchick V, Sherman MH, Cukierman E, Pickering AM, Maitra A, Sahai V, Morgan MA, Nagrath S, Lawrence TS, Nagrath D. Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. Nat Metab 2020;2:775-92. [PMID: 32694827 DOI: 10.1038/s42255-020-0226-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
11 Vickman RE, Franco OE, Hayward SW. Contributions of carcinoma-associated fibroblasts to the prostate cancer microenvironment. Current Opinion in Endocrine and Metabolic Research 2020;10:1-6. [DOI: 10.1016/j.coemr.2020.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nsengimana B, Khan FA, Ngowi EE, Zhou X, Jin Y, Jia Y, Wei W, Ji S. Processing body (P-body) and its mediators in cancer. Mol Cell Biochem 2022. [PMID: 35089528 DOI: 10.1007/s11010-022-04359-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Niu Y, Chen J, Qiao Y. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe. Front Immunol 2022;13:836223. [DOI: 10.3389/fimmu.2022.836223] [Reference Citation Analysis]
14 Méndez-lópez LF. Revisiting Epithelial Carcinogenesis. IJMS 2022;23:7437. [DOI: 10.3390/ijms23137437] [Reference Citation Analysis]
15 Schor AM, Woolston AM, Kankova K, Harada K, Aljorani LE, Perrier S, Felts PA, Keatch RP, Schor SL. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment. Adv Exp Med Biol 2021;1329:351-97. [PMID: 34664248 DOI: 10.1007/978-3-030-73119-9_18] [Reference Citation Analysis]
16 Yoshida GJ. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res 2020;39:112. [PMID: 32546182 DOI: 10.1186/s13046-020-01611-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 18.5] [Reference Citation Analysis]
17 Licitra F, Giovannelli P, Di Donato M, Monaco A, Galasso G, Migliaccio A, Castoria G. New Insights and Emerging Therapeutic Approaches in Prostate Cancer. Front Endocrinol 2022;13:840787. [DOI: 10.3389/fendo.2022.840787] [Reference Citation Analysis]
18 Lambrou GI, Poulou M, Giannikou K, Themistocleous M, Zaravinos A, Braoudaki M. Differential and Common Signatures of miRNA Expression and Methylation in Childhood Central Nervous System Malignancies: An Experimental and Computational Approach. Cancers (Basel) 2021;13:5491. [PMID: 34771655 DOI: 10.3390/cancers13215491] [Reference Citation Analysis]
19 Liang ZQ, Gao L, Chen JH, Dai WB, Su YS, Chen G. Downregulation of the Coiled-Coil Domain Containing 80 and Its Perspective Mechanisms in Ovarian Carcinoma: A Comprehensive Study. Int J Genomics 2021;2021:3752871. [PMID: 34820451 DOI: 10.1155/2021/3752871] [Reference Citation Analysis]
20 Wang F, Zhang W, Song Z, Wang M, Wu H, Yang Y, Chen R. A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation. J Cancer Res Clin Oncol 2021;147:469-80. [PMID: 33221996 DOI: 10.1007/s00432-020-03455-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]